This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200608-1164OCv1 175/10/1036    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vanscoy, L. L. Articles by Cutting, G. R. Search for Related Content PubMed PubMed Citation Articles by Vanscoy, L. L. Articles by Cutting, G. R.

Heritability of Lung Disease Severity in Cystic Fibrosis

Divisions of ¹ Pediatric Respiratory Sciences and ² Pediatric Endocrinology, and ³ McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; ⁴ University of Maryland Medical System, Baltimore, Maryland; ⁵ Rutgers University, New Brunswick, New Jersey; and ⁶ Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Correspondence and requests for reprints should be addressed to Garry R. Cutting, M.D., Johns Hopkins Medical Institutions, BRB 559, 733 North Broadway, Baltimore, MD 21205. E-mail: gcutting{at}jhmi.edu

Rationale: Obstructive lung disease, the major cause of mortality in cystic fibrosis (CF), is poorly correlated with mutations in the disease-causing gene, indicating that other factors determine severity of lung disease.

Objectives: To quantify the contribution of modifier genes to variation in CF lung disease severity.

Methods: Pulmonary function data from patients with CF living with their affected twin or sibling were converted into reference values based on both healthy and CF populations. The best measure of FEV₁ within the last year was used for cross-sectional analysis. FEV₁ measures collected over at least 4 years were used for longitudinal analysis. Genetic contribution to disease variation (i.e., heritability) was estimated in two ways: by comparing similarity of lung function in monozygous (MZ) twins ( 100% gene sharing) with that of dizygous (DZ) twins/siblings ( 50% gene sharing), and by comparing similarity of lung function measures for related siblings to similarity for all study subjects.

Measurements and Main Results: Forty-seven MZ twin pairs, 10 DZ twin pairs, and 231 sibling pairs (of a total of 526 patients) with CF were studied. Correlations for all measures of lung function for MZ twins (0.82–0.91, p < 0.0001) were higher than for DZ twins and siblings (0.50–0.64, p < 0.001). Heritability estimates from both methods were consistent for each measure of lung function and ranged from 0.54 to 1.0. Heritability estimates generally increased after adjustment for differences in nutritional status (measured as body mass index z-score).

Conclusions: Our heritability estimates indicate substantial genetic control of variation in CF lung disease severity, independent of CFTR genotype.

Key Words: genetics • pulmonary function

AT A GLANCE COMMENTARY Scientific Knowledge on the Subject Severity of cystic fibrosis (CF) lung disease is poorly correlated with CFTR mutation. Although numerous candidates have been investigated, the role for modifier genes in CF lung disease severity has not been verified or quantified. What This Study Adds to the Field A significant portion of variability in CF lung disease is due to modifier genes.

 

This article has been cited by other articles:

				S. M. Blackman, S. Hsu, L. L. Vanscoy, J. M. Collaco, S. E. Ritter, K. Naughton, and G. R. Cutting Genetic Modifiers Play a Substantial Role in Diabetes Complicating Cystic Fibrosis J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1302 - 1309. [Abstract] [Full Text] [PDF]

				L. A. Bremer, S. M. Blackman, L. L. Vanscoy, K. E. McDougal, A. Bowers, K. M. Naughton, D. J. Cutler, and G. R. Cutting Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis Hum. Mol. Genet., July 15, 2008; 17(14): 2228 - 2237. [Abstract] [Full Text] [PDF]

				F. J. Accurso Update in Cystic Fibrosis 2007 Am. J. Respir. Crit. Care Med., May 15, 2008; 177(10): 1058 - 1061. [Full Text] [PDF]

				J. M. Collaco, L. Vanscoy, L. Bremer, K. McDougal, S. M. Blackman, A. Bowers, K. Naughton, J. Jennings, J. Ellen, and G. R. Cutting Interactions Between Secondhand Smoke and Genes That Affect Cystic Fibrosis Lung Disease JAMA, January 30, 2008; 299(4): 417 - 424. [Abstract] [Full Text] [PDF]

				L. B. Ware Clinical Year in Review III: Asthma, Lung Transplantation, Cystic Fibrosis, Acute Respiratory Distress Syndrome Proceedings of the ATS, September 15, 2007; 4(6): 489 - 493. [Full Text] [PDF]